Recent News

• 06.06.2025 - Shawn Guertin
• 04.29.2025 - 2023 Diversity, Equity & Inclusion Annual Report
• 04.15.2025 - Evolent program achieves 20% reduction in use of low-value oncology regimens
• 03.21.2025 - Jihad Kudsi, MD, ABOM, MBA, MSF, FASMBS, FACS
• 03.14.2025 - July 2025 Cardiology Program Changes

Recent Filings

• 06.05.2025 - 8-K Current report
• 06.03.2025 - 8-K Current report
• 05.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.08.2025 - 8-K Current report
• 05.08.2025 - EX-99.1 EX-99.1
• 04.25.2025 - ARS Annual Report to Security Holders
• 04.25.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.25.2025 - DEF 14A Other definitive proxy statements